Revenio Group Oyj (HEL:REG1V)

Market Cap	705.88M
Revenue (ttm)	103.80M
Net Income (ttm)	18.50M
Shares Out	26.60M
EPS (ttm)	0.70
PE Ratio	38.19
Forward PE	27.65
Dividend	0.40 (1.48%)
Ex-Dividend Date	Apr 5, 2024

Volume	16,887
Average Volume	21,418
Open	27.08
Previous Close	26.96
Day's Range	26.32 - 27.10
52-Week Range	23.36 - 35.84
Beta	1.39
RSI	33.36
Earnings Date	Feb 13, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.80 million, an increase of 7.25% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.19%.